Observational Study of Neurofilament Light Chain (NfL) as a Biomarker in Asymptomatic Carriers of the Transthyretin (TTR) Variants and Patients With Hereditary Transthyretin-mediated (hATTR) Amyloidosis With Polyneuropathy
Clinical trial NCT06360289 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06360289
- Sponsor
- Alnylam Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-04-25
- Primary completion
- 2027-12-15
- Enrollment
- 346
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.